Babar, Z., and Areesha Babar. “FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care”. Journal of the Pakistan Medical Association, vol. 75, no. 07, July 2025, pp. 1156-, doi:10.47391/JPMA.21951.